Eurofins Scientific SE
Eurofins Scientific SE (ERFSF) Revenue
Annual & quarterly revenue history · segment & region breakdown
ERFSF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsEurofins Scientific SE trailing twelve-month (TTM) revenue is $14.25B, an increase of 4.92% year-over-year from $7.29B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $7.29B | +$0.34B | +4.92% |
| 2024-12-31 | $6.95B | +$0.44B | +6.70% |
| 2023-12-31 | $6.51B | -$0.20B | -2.94% |
| 2022-12-31 | $6.71B | -$0.01B | -0.08% |
| 2021-12-31 | $6.72B | +$1.28B | +23.51% |
| 2020-12-31 | $5.44B | +$0.88B | +19.20% |
| 2019-12-31 | $4.56B | +$0.78B | +20.67% |
| 2018-12-31 | $3.78B | +$0.81B | +27.25% |
| 2017-12-31 | $2.97B | +$0.43B | +17.14% |
| 2016-12-31 | $2.54B | +$0.59B | +30.08% |
Compare revenue vs peers
Medical - Diagnostics & ResearchCompare ERFSF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Eurofins Scientific SE receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Eurofins Scientific SE reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Eurofins Scientific SE's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ERFSF revenue · 4 questionsERFSF's trailing twelve-month (TTM) revenue is $14.25B. That is an increase of 4.92% year-over-year from $7.29B in FY2025.
▸ Source: FMP · Eurofins Scientific SE SEC filings · GAAP · Eurofins Scientific SE SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026